- Home
- GRDN vs ACHC Comparison
GRDN vs ACHC Comparison
Compare GRDN & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRDN
- ACHC
- Stock Information
- Founded
- GRDN 2004
- ACHC 2005
- Country
- GRDN United States
- ACHC United States
- Employees
- GRDN N/A
- ACHC N/A
- Industry
- GRDN Retail-Drug Stores and Proprietary Stores
- ACHC Medical Specialities
- Sector
- GRDN Consumer Staples
- ACHC Health Care
- Exchange
- GRDN Nasdaq
- ACHC Nasdaq
- Market Cap
- GRDN 1.7B
- ACHC 1.7B
- IPO Year
- GRDN 2024
- ACHC N/A
- Fundamental
- Price
- GRDN $24.90
- ACHC $24.09
- Analyst Decision
- GRDN Strong Buy
- ACHC Strong Buy
- Analyst Count
- GRDN 3
- ACHC 12
- Target Price
- GRDN $27.00
- ACHC $35.33
- AVG Volume (30 Days)
- GRDN 287.0K
- ACHC 2.6M
- Earning Date
- GRDN 11-10-2025
- ACHC 10-31-2025
- Dividend Yield
- GRDN N/A
- ACHC N/A
- EPS Growth
- GRDN N/A
- ACHC N/A
- EPS
- GRDN N/A
- ACHC 1.52
- Revenue
- GRDN $1,326,604,000.00
- ACHC $3,229,609,000.00
- Revenue This Year
- GRDN $16.17
- ACHC $7.23
- Revenue Next Year
- GRDN $2.31
- ACHC $6.95
- P/E Ratio
- GRDN N/A
- ACHC $15.87
- Revenue Growth
- GRDN 18.53
- ACHC 5.64
- 52 Week Low
- GRDN $16.91
- ACHC $17.13
- 52 Week High
- GRDN $30.39
- ACHC $60.52
- Technical
- Relative Strength Index (RSI)
- GRDN 50.11
- ACHC 48.77
- Support Level
- GRDN $23.37
- ACHC $23.50
- Resistance Level
- GRDN $24.86
- ACHC $25.21
- Average True Range (ATR)
- GRDN 0.96
- ACHC 1.12
- MACD
- GRDN -0.03
- ACHC -0.24
- Stochastic Oscillator
- GRDN 48.58
- ACHC 15.01
About GRDN Guardian Pharmacy Services Inc. Class A Common Stock
Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.